Tampere Traumatic Head and Brain Injury Study (TheBrainS)

October 5, 2021 updated by: Teemu Luoto, Tampere University Hospital
Tampere Traumatic head and brain injury study is a prospective study aiming to explore neuroradiological, neuropsychological, neurological and biochemical aspects of mild traumatic brain injury (mtbi). The main interest is on factors that effect to the outcome after mtbi. The study is conducted in Tampere University Hospital's emergency department between the 1st of August 2010 and 31st of July 2013.

Study Overview

Status

Completed

Conditions

Detailed Description

Aims of the study:

  1. To improve clinical assessment of mTBI in the acute phase
  2. To assemble better knowledge of diffusion tensor imaging as a diagnostic tool in mTBI
  3. To improve neuropsychological evaluation of mTBI Main focus on psychosocial functioning / outcome / correlates E.g. Resilience, PTSD

Study Type

Observational

Enrollment (Actual)

115

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tampere, Finland, 33521
        • Tampere University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Community sample consisting of consecutive mild traumatic brain injury patients metting the enrollment criteria.

Description

Inclusion Criteria:

  • WHO's mtbi criteria
  • Inhabitant of Pirkanmaa hospital district
  • Age between 18 and 60 years

Exclusion Criteria:

  • Detrimental alcohol use
  • Drug addiction
  • Chronic neurological disease
  • Earlier brain injury
  • Diagnosed psychiatric disease
  • Hearing or sight deficiency
  • Native language other than finnish

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Teemu M. Luoto, M.D., Tampere University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2010

Primary Completion (ACTUAL)

February 1, 2021

Study Completion (ACTUAL)

February 1, 2021

Study Registration Dates

First Submitted

September 1, 2011

First Submitted That Met QC Criteria

September 1, 2011

First Posted (ESTIMATE)

September 2, 2011

Study Record Updates

Last Update Posted (ACTUAL)

October 6, 2021

Last Update Submitted That Met QC Criteria

October 5, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • R10027

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.